Published in Ophthalmology on May 01, 2004
Computer-based Screening for Diabetic Retinopathy | NCT01614327
Photoacoustic ophthalmoscopy for in vivo retinal imaging. Opt Express (2010) 3.31
Imaging in diabetic retinopathy. Middle East Afr J Ophthalmol (2015) 1.43
Diabetic retinopathy: an update. Indian J Ophthalmol (2008) 1.18
Comparison Among Methods of Retinopathy Assessment (CAMRA) Study: Smartphone, Nonmydriatic, and Mydriatic Photography. Ophthalmology (2015) 1.03
The use of retinal photography in nonophthalmic settings and its potential for neurology. Neurologist (2012) 0.99
Telemedicine in diabetic retinopathy: current status and future directions. Middle East Afr J Ophthalmol (2015) 0.96
Accuracy of primary care clinicians in screening for diabetic retinopathy using single-image retinal photography. Ann Fam Med (2008) 0.93
Retinal Imaging and Image Analysis. IEEE Trans Med Imaging (2010) 0.92
Non-mydriatic ocular fundus photography and telemedicine: past, present, and future. Neuroophthalmology (2013) 0.89
A novel device for accurate and efficient testing for vision-threatening diabetic retinopathy. J Diabetes Complications (2015) 0.89
Analysis of foveal avascular zone for grading of diabetic retinopathy severity based on curvelet transform. Graefes Arch Clin Exp Ophthalmol (2012) 0.85
Screening for Diabetic Retinopathy Using a Portable, Noncontact, Nonmydriatic Handheld Retinal Camera. J Diabetes Sci Technol (2016) 0.84
Optical imaging of mitochondrial redox state in rodent model of retinitis pigmentosa. J Biomed Opt (2013) 0.83
Automated detection of diabetic retinopathy: barriers to translation into clinical practice. Expert Rev Med Devices (2010) 0.83
P-selectin Plasma Levels and Genetic Variant Associated With Diabetic Retinopathy in African Americans. Am J Ophthalmol (2015) 0.83
Potential bias in ophthalmic pharmaceutical clinical trials. Clin Ophthalmol (2008) 0.81
Evaluation of diabetic retinopathy screening using a non-mydriatic retinal digital camera in primary care settings in south Israel. Int Ophthalmol (2013) 0.81
Ultra-wide-field imaging in diabetic retinopathy; an overview. J Curr Ophthalmol (2016) 0.79
Screening for diabetic retinopathy using new mydriasis-free, full-field flicker ERG recording device. Sci Rep (2016) 0.79
Retinopathy of prematurity management using single-image vs multiple-image telemedicine examinations. Am J Ophthalmol (2008) 0.78
Retinal Imaging Techniques for Diabetic Retinopathy Screening. J Diabetes Sci Technol (2016) 0.77
Euglycemic progression: worsening of diabetic retinopathy in poorly controlled type 2 diabetes in minorities. Diabetes Res Clin Pract (2013) 0.76
Prevalence of undiagnosed diabetic retinopathy among inpatients with diabetes: the diabetic retinopathy inpatient study (DRIPS). BMJ Open Diabetes Res Care (2016) 0.76
Association Between Diabetic Macular Edema and Cardiovascular Events in Type 2 Diabetes Patients: A Multicenter Observational Study. Medicine (Baltimore) (2015) 0.75
The Accuracy and Reliability of Crowdsource Annotations of Digital Retinal Images. Transl Vis Sci Technol (2016) 0.75
Plantar fascia enthesopathy is highly prevalent in diabetic patients without peripheral neuropathy and correlates with retinopathy and impaired kidney function. PLoS One (2017) 0.75
Regional Image Features Model for Automatic Classification between Normal and Glaucoma in Fundus and Scanning Laser Ophthalmoscopy (SLO) Images. J Med Syst (2016) 0.75
A Multi-Center Diabetes Eye Screening Study in Community Settings: Study Design and Methodology. Ophthalmic Epidemiol (2016) 0.75
Free Triiodothyronine Levels Are Associated with Diabetic Nephropathy in Euthyroid Patients with Type 2 Diabetes. Int J Endocrinol (2015) 0.75
Diabetic retinopathy screening using single-field digital fundus photography at a district level in Costa Rica: a pilot study. Int Ophthalmol (2011) 0.75
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology (2010) 10.28
Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med (2012) 8.83
Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol (2003) 4.78
Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. Mol Ther (2005) 4.74
Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology (2011) 4.15
Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy success. Proc Natl Acad Sci U S A (2005) 4.04
Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration. Mol Ther (2009) 3.93
A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology (2007) 3.49
Evolving guidelines for intravitreous injections. Retina (2004) 3.39
Reversal of blindness in animal models of leber congenital amaurosis using optimized AAV2-mediated gene transfer. Mol Ther (2008) 3.28
Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. Am J Ophthalmol (2004) 2.98
Acute zonal occult outer retinopathy: a long-term follow-up study. Am J Ophthalmol (2002) 2.92
AAV2 gene therapy readministration in three adults with congenital blindness. Sci Transl Med (2012) 2.87
Comparison of retrobulbar and sub-Tenon's capsule injection of local anesthetic in vitreoretinal surgery. Ophthalmology (2005) 2.79
Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Mol Vis (2003) 2.68
Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol (2005) 2.66
Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator. Mol Ther (2008) 2.59
In utero gene therapy rescues vision in a murine model of congenital blindness. Mol Ther (2004) 2.56
Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol (2007) 2.53
Vascular endothelial growth factor is a critical stimulus for diabetic macular edema. Am J Ophthalmol (2006) 2.50
Oct-based interpretation of the vitreomacular interface and indications for pharmacologic vitreolysis. Retina (2013) 2.49
Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Genet (2004) 2.30
Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study. Am J Ophthalmol (2012) 2.30
Diagnostic sensitivity and specificity of dark adaptometry for detection of age-related macular degeneration. Invest Ophthalmol Vis Sci (2014) 2.20
Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13. Ophthalmology (2004) 2.19
Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection. Mol Ther (2006) 2.13
Clinical practice. Retinal-vein occlusion. N Engl J Med (2010) 2.05
Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology (2010) 2.02
Transvitreal fibrinoid pseudoendophthalmitis after diabetic vitrectomy. Retina (2013) 1.97
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3. Ophthalmology (2003) 1.96
Age-related macular degeneration is associated with incident myocardial infarction among elderly Americans. Ophthalmology (2006) 1.91
Endophthalmitis caused by Streptococcus pneumoniae. Am J Ophthalmol (2004) 1.91
Intravitreal bevacizumab (Avastin) injection associated with regression of retinal neovascularization caused by sickle cell retinopathy. Acta Ophthalmol Scand (2006) 1.90
Retinal thickness analysis by race, gender, and age using Stratus OCT. Am J Ophthalmol (2009) 1.86
Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina (2002) 1.86
Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital Amaurosis type 2. Ophthalmology (2013) 1.85
A placebo-controlled trial of microplasmin intravitreous injection to facilitate posterior vitreous detachment before vitrectomy. Ophthalmology (2010) 1.84
Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Arch Ophthalmol (2010) 1.82
Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosis. Hum Gene Ther (2006) 1.81
Retinal pigment epitheliopathy, macular telangiectasis, and intraretinal crystal deposits in HIV-positive patients receiving ritonavir. Retina (2011) 1.80
Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes. Ophthalmology (2007) 1.79
Intravitreal triamcinolone acetonide for macular edema associated with diabetic retinopathy and venous occlusive disease: it's time for clinical trials. Arch Ophthalmol (2005) 1.77
Intravitreal bevacizumab (Avastin) associated with the regression of subretinal neovascularization in idiopathic juxtafoveolar retinal telangiectasis. Graefes Arch Clin Exp Ophthalmol (2006) 1.75
Vitreoretinal morphology in active ocular toxoplasmosis: a prospective study by optical coherence tomography. Br J Ophthalmol (2006) 1.74
Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol (2004) 1.74
Photodynamic therapy using verteporfin for choroidal neovascularization in angioid streaks. Am J Ophthalmol (2003) 1.69
Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema: one-year results of a randomized clinical trial. Am J Ophthalmol (2008) 1.68
The dexamethasone drug delivery system: indications and evidence. Adv Ther (2011) 1.67
Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome. Am J Ophthalmol (2009) 1.64
Gene therapy for choroideremia: in vitro rescue mediated by recombinant adenovirus. Vision Res (2003) 1.63
AAV-mediated gene therapy for choroideremia: preclinical studies in personalized models. PLoS One (2013) 1.62
Delayed intraocular foreign body removal without endophthalmitis during Operations Iraqi Freedom and Enduring Freedom. Ophthalmology (2007) 1.62
Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology (2008) 1.60
Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study. Retina (2007) 1.59
Sutureless scleral fixation of intraocular lenses: outcomes of two approaches. The 2014 Yasuo Tano Memorial Lecture. Graefes Arch Clin Exp Ophthalmol (2014) 1.59
Intravitreal bevacizumab for choroidal neovascularization caused by AMD (IBeNA Study): results of a phase 1 dose-escalation study. Invest Ophthalmol Vis Sci (2006) 1.59
Correlation of visual acuity and macular thickness measured by optical coherence tomography in patients with persistent macular edema. Retina (2010) 1.56
Dosage thresholds for AAV2 and AAV8 photoreceptor gene therapy in monkey. Sci Transl Med (2011) 1.54
Macular fibrosis in Coats disease. Retina (2010) 1.54
Traumatic retinal break from viscoelastic cannula during cataract surgery. Arch Ophthalmol (2003) 1.54
The human visual cortex responds to gene therapy-mediated recovery of retinal function. J Clin Invest (2011) 1.52
Exogenous fungal endophthalmitis: microbiology and clinical outcomes. Ophthalmology (2008) 1.51
Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs. Proc Natl Acad Sci U S A (2002) 1.50
Vascular endothelial growth factor Trap-Eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS study. Ophthalmology (2012) 1.48
Diabetic macular edema: what is focal and what is diffuse? Am J Ophthalmol (2008) 1.47
SCORE Study report 3: study design and baseline characteristics. Ophthalmology (2009) 1.47
Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the American Academy of Ophthalmology. Ophthalmology (2008) 1.47
Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration. Ophthalmology (2005) 1.47
Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration. Proc Natl Acad Sci U S A (2011) 1.47
Intraoperative ketorolac and eye pain after viteoretinal surgery: a prospective, randomized, placebo-controlled study. Retina (2003) 1.46
Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study). Retina (2006) 1.45
Persistent diabetic macular edema is associated with elevated hemoglobin A1c. Am J Ophthalmol (2005) 1.43
Immediate indocyanine green angiography and optical coherence tomography evaluation after photodynamic therapy for subfoveal choroidal neovascularization. Retina (2003) 1.41
Disclosure of resident involvement in ophthalmic surgery. Arch Ophthalmol (2012) 1.40
Prevalence and predictors of ocular complications associated with cataract surgery in United States veterans. Ophthalmology (2010) 1.40
Reducing the risk of endophthalmitis following intravitreal injections. Retina (2007) 1.39
Presumed sterile endophthalmitis following intravitreal triamcinolone acetonide injection. Ophthalmic Surg Lasers Imaging (2005) 1.38
Endophthalmitis caused by Pseudomonas aeruginosa. Ophthalmology (2003) 1.36
Comparison of time-domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema. Invest Ophthalmol Vis Sci (2008) 1.36
Comparison between retinal thickness analyzer and optical coherence tomography for assessment of foveal thickness in eyes with macular disease. Am J Ophthalmol (2002) 1.36
Systemic but not intraocular Epo gene transfer protects the retina from light-and genetic-induced degeneration. Mol Ther (2004) 1.35
Safety and efficacy of subretinal readministration of a viral vector in large animals to treat congenital blindness. Sci Transl Med (2010) 1.35
Impact of resident participation in cataract surgery on operative time and cost. Ophthalmology (2011) 1.35
The 1-year results of CLEAR-IT 2, a phase 2 study of vascular endothelial growth factor trap-eye dosed as-needed after 12-week fixed dosing. Ophthalmology (2011) 1.34
Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant. Ophthalmology (2012) 1.32
Assessment of vision-related function in patients with age-related macular degeneration. Ophthalmology (2002) 1.32
Small-gauge pars plana vitrectomy: a report by the American Academy of Ophthalmology. Ophthalmology (2010) 1.32
Open globe injuries with positive intraocular cultures: factors influencing final visual acuity outcomes. Ophthalmology (2003) 1.29
Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol (2004) 1.28
Regression of a subfoveal choroidal metastasis of colorectal carcinoma after intravitreous bevacizumab treatment. Arch Ophthalmol (2008) 1.27
Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis. Am J Ophthalmol (2004) 1.26
Combined phacoemulsification, intraocular lens implantation, and vitrectomy for eyes with coexisting cataract and vitreoretinal pathology. Am J Ophthalmol (2003) 1.26
Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: a phase I trial. Retina (2011) 1.25
Anti-vascular endothelial growth factor pharmacotherapy for diabetic macular edema: a report by the American Academy of Ophthalmology. Ophthalmology (2012) 1.23
Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmology (2011) 1.22